The US District Court for the district of Columbia granted SPARC's motion for summary judgment and held that "FDA's ...

Sezaby is a benzyl alcohol and propylene glycol free formulation of phenobarbital sodium powder for injection. It was ...

Sun Pharma Advanced Research Company surged for a second straight session after a U.S. court ruled in its favour on the ...

Get Up to 10% Off on All Market Research Reports!Report OverviewThe global fetal monitoring market is positioned for steady growth, advancing at an estimated CAGR of nearly 7% in the coming years as ...

"We are pleased with the ruling issued by the US District Court, as it validates SPARC's long held position on this matter," ...

Sun Pharma Advanced Research Company shares rose 11.5% to ₹179.50 on December 3, following a court ruling in its favor regarding a Priority Review Voucher for Sezaby. Despite recent losses, the stock ...

Mumbai: Sun Pharma Advanced Research Company has announced that the U.S. District Court for the District of Columbia has ...

India’s equity benchmarks fell for a third consecutive session on Tuesday as concerns over foreign outflows and ...

Round-the-clock fetal monitoring leads to unnecessary C-sections. But it’s used in nearly every birth because of business and ...

SPARC: The stock jumped 20 per cent to touch its upper price band of Rs 161.10, although it remains down 19.73 per cent on a year-to-date (YTD) basis.

Sun Pharma Advanced Research Company (SPARC) was locked in 20% upper circuit at Rs 161.10 after the company announced that the U.S. District Court has granted summary judgement in favour of SPARC for ...

A juvenile orange-fronted parakeet seized by the U.S. Fish and Wildlife Service Office of Law Enforcement at the Otay Mesa ...